biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	741EDDF8-49A3-4585-9DB7-3417514AB8AB
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A11C-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A11C-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A11C-01A
biospecimen__bio__biospecimen_barcode_bottom	0108433580
biospecimen__bio__day_of_creation	15
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-DD-A11C.35CD5B20-BF61-4D28-AC7F-2CDC959382CD.pdf
biospecimen__bio__plate_column	4
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	E
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.80
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2010
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A11C
biospecimen__shared__patient_id	A11C
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	DA3B7666-BEF9-465D-88C6-955AD72EE9C2
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.6
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	2.3
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.9
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	11
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	69
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A11C-F38786
clinical__clin_shared__bcr_followup_uuid	3C9E4CD1-2B50-40E4-A6FF-B08D0F112AA0
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	21
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	12
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	391
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	RX
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2006
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	4a6ba817-2b50-47db-87e3-72332d505870
gdc__aliquots__concentration	0.14
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A11C-01A-11R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	f20cf555-a391-4c95-a6ce-a35e669a96e5
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.89
gdc__analytes__analyte_id	8caf6ad4-f3f7-4981-a417-5159aa20ccf2
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	023a1ad1-fb16-437e-9806-5063b47f76bd
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:40:54.554160-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	77c18747-87e6-5d35-8f07-12a2950d7ed6
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1937
gdc__diagnoses__age_at_diagnosis	25403
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-25403.0
gdc__diagnoses__days_to_last_follow_up	662.0
gdc__diagnoses__diagnosis_id	1d3adbb8-abe8-5fac-8c6b-a1fe482bbaa4
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	35.55324314949705
gdc__exposures__exposure_id	e37b38f3-7d37-5ecb-bb94-7aff47f14a46
gdc__exposures__height	186.0
gdc__exposures__weight	123.0
gdc__file_id	6564f6a0-1d07-4970-8eec-7164b674e052
gdc__file_name	dd7dac70-c361-4516-b162-c05fe2e30e75.mirbase21.mirnas.quantification.txt
gdc__file_size	50133
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	704a0b2c52c2e3e85e9a11653673d30e
gdc__portions__is_ffpe	false
gdc__portions__portion_id	b658f9c5-effe-4afa-9418-e08dcc0ed441
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1703
gdc__samples__initial_weight	220.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	35CD5B20-BF61-4D28-AC7F-2CDC959382CD
gdc__samples__sample_id	bf79978c-a9c7-429e-bb78-20eea5f16fdf
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	2.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	80.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	db4295ff-8916-4130-a2e1-b929814b25cf
gdc__submitter_id	mirna_swap_dr11_307_MirnaExpression99c20f7e-2fd2-41c5-b1b8-d2f80994fbcc_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	0c6b43df-dc04-5911-b332-f93bb65f9033
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:15.349+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/4a6ba817-2b50-47db-87e3-72332d505870-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/4a6ba817-2b50-47db-87e3-72332d505870-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129504
manually_curated__local_md5	28a912d58bbd9af6e24ae0bdf0d86327
manually_curated__opengdc_download_date	2018-10-16T17:12:02.000420+02:00
manually_curated__opengdc_file_md5	d5556dcba977f85b6cb8850ca1ae6d1a
manually_curated__opengdc_file_size	50132
manually_curated__opengdc_id	4a6ba817-2b50-47db-87e3-72332d505870-meq
manually_curated__origin_file_size	129504
manually_curated__origin_last_modified_date	Tue Oct 16 17:53:00 CEST 2018
manually_curated__origin_md5	28a912d58bbd9af6e24ae0bdf0d86327
manually_curated__tissue_status	tumoral
